7th Circ. Revives Baxter Investor Suit Over $588M Recall
The Seventh Circuit revived a shareholder derivative suit accusing Baxter International Inc. directors of not correcting infusion pump problems that led to a recall costing the health care company $588 million,...To view the full article, register now.
Already a subscriber? Click here to view full article